The effect of low-dose apixaban in the treatment of symptomatic cases of radial artery occlusion following radial artery angiography.
Not Applicable
Recruiting
- Conditions
- Radial artery occlusion following angiography.
- Registration Number
- IRCT20221013056161N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
People who have undergone radial artery angiography
Symptoms related to radial artery occlusion (such as pain and palpable radial pulse)
Confirmed by Doppler imaging
Exclusion Criteria
Lack of patient satisfaction
The need for a therapeutic dose of anticoagulants
The use of other anticoagulants
Severe symptoms of vascular occlusion that require rapid intervention to restore the arterial channel
Contraindications for apixaban use include severe drug sensitivity
Active clinical and pathological bleeding such as gastrointestinal and cerebral
hemostasis disorder and advanced renal failure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Radial artery occlusion. Timepoint: Before the intervention and 28 days after the intervention. Method of measurement: The inclusion criteria are people who have undergone radial artery angiography and then have symptoms related to radial artery occlusion (such as pain and palpable radial pulse), which can be confirmed by Doppler imaging. All ultrasounds are performed by a radiologist.
- Secondary Outcome Measures
Name Time Method